Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/IN/Fort Wayne
Updated November 2026 from ClinicalTrials.gov

Paid Clinical Trials in Fort Wayne, IN

Studies commonly pay $75 to $4,500 per completed study

116 clinical trials are currently recruiting participants within 30 miles of Fort Wayne. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

116studies recruiting
2+research centers nearby
3condition categories
Live from the NIH registry

Studies recruiting near Fort Wayne right now

Top 25 of 116 recruiting studies, sorted by proximity — each links to its official registry page

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma Phase 3 Interventional 880 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: NRG Oncology

A Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of Gamunex in Participants With Secondary Antibody Deficiency Associated With Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma

Chronic Lymphocytic Leukemia, Multiple Myeloma, or Non-Hodgkin Lymphoma Phase 3 Interventional 49 participants sought
Study Site 101 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Grifols Biologicals, LLC

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung Phase 2 Interventional 480 participants sought
Fort Wayne Medical Oncology and Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Janssen Research & Development, LLC

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Alliance for Clinical Trials in Oncology

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

Ovarian Cancer, Fallopian Tube Cancer Phase 3 Interventional 770 participants sought
Parkview Research Center at Parkview Regional Medical Center ( Site 0003) — Fort Wayne, Indiana (3.0 mi) · Sponsor: Merck Sharp & Dohme LLC

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: SWOG Cancer Research Network

Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement

Aortic Stenosis, Coronary Artery Disease N/A Interventional 4,000 participants sought
Parkview Research Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: University of British Columbia

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Idiopathic Hypersomnia Phase 3 Interventional 248 participants sought
Fort Wayne Neurological Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Harmony Biosciences Management, Inc.

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 734 participants sought
Parkview Packnett Family Cancer Institute — Fort Wayne, Indiana (3.0 mi) · Sponsor: NovoCure GmbH

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Parkview Research Center at Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Eli Lilly and Company

Testing Docetaxel-Cetuximab or the Addition of an Immunotherapy Drug, Atezolizumab, to the Usual Chemotherapy and Radiation Therapy in High-Risk Head and Neck Cancer

Oropharyngeal p16INK4a-Negative Squamous Cell Carcinoma, Stage III Hypopharyngeal Squamous Cell Carcinoma AJCC v7 Phase 2, Phase 3 Interventional 613 participants sought
Radiation Oncology Associates PC — Fort Wayne, Indiana (3.0 mi) · Sponsor: National Cancer Institute (NCI)

Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 3 Interventional 582 participants sought
Research Site — Fort Wayne, Indiana (3.0 mi) · Sponsor: AstraZeneca

A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)

Alzheimer Disease Phase 4 Interventional 150 participants sought
NexGen Research — Fort Wayne, Indiana (3.0 mi) · Sponsor: Alpha Cognition, Inc

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
Parkview Research Center at Parkview Regional Medical Center — Fort Wayne, Indiana (3.0 mi) · Sponsor: Eli Lilly and Company

A Study to Assess A Change in Disease Activity and Adverse Events of Intravenous Etentamig and Daratumumab (Etentamig+D) Compared to Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Adult Participants With Newly Diagnosed Multiple Myeloma Not Eligible for Transplant

Multiple Myeloma Phase 2, Phase 3 Interventional 680 participants sought
Fort Wayne Medical Oncology And Hematology /ID# 278141 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie

Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations

Non Small Cell Lung Carcinoma, c-MET Phase 1, Phase 2 Interventional 252 participants sought
Parkview Comprehensive Cancer Center /ID# 271879 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

Heart Failure With Preserved Ejection Fraction Phase 2 Interventional 90 participants sought
Local Institution - 26 — Fort Wayne, Indiana (3.0 mi) · Sponsor: Edgewise Therapeutics, Inc.

Assessing Connected-Health, Pressure-Monitoring Technology for Improving Compression Therapy in Venous Leg Ulcer Treatment

Venous Leg Ulcers (VLUs) N/A Interventional 40 participants sought
Parkview Center for Wound Healing — Fort Wayne, Indiana (3.0 mi) · Sponsor: Feeltect Limited

A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer

Non-Small Cell Lung Cancer, c-MET Phase 2, Phase 3 Interventional 490 participants sought
Parkview Research Center /ID# 277651 — Fort Wayne, Indiana (3.0 mi) · Sponsor: AbbVie

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

B-cell Malignancy, Chronic Lymphocytic Leukemia Phase 1 Interventional 120 participants sought
American Oncology Partners — Fort Wayne, Indiana (3.0 mi) · Sponsor: Carna Biosciences, Inc.

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 Inhibitors

Non Small Cell Lung Cancer Phase 3 Interventional 630 participants sought
Fort Wayne Medical Oncology - 1133 — Fort Wayne, Indiana (3.0 mi) · Sponsor: OncoC4, Inc.

A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or FOLFIRI as First-line Treatment in Participants With KRAS/NRAS and BRAF Wild-type Unresectable or Metastatic Left-sided Colorectal Cancer

Colorectal Neoplasms Phase 3 Interventional 1,000 participants sought
Fort Wayne Medical Oncology & Hematology — Fort Wayne, Indiana (3.0 mi) · Sponsor: Janssen Research & Development, LLC
Actively enrolling

Studies you may be able to join near Fort Wayne

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Google-rated

Top-rated research centers in Fort Wayne

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Salus Research

★ 5.0
1220 Medical Park Dr A, Fort Wayne, IN 46825
(260) 755-1099
"Best of everything! Ten stars out of five!!"
— Bruce Wilder, 5★

Avenues Recovery Center at Fort Wayne

★ 4.9 (957 reviews)
2626 Fairfield Ave, Fort Wayne, IN 46807
(260) 909-8343
"I chose Avenues Ft. Wayne and have not one time felt regret over the decision.<br>The beds here are comfortable.<br>The rooms and facilities are clea…"
— Jonathan Buuck, 5★

Clinical trials in Fort Wayne: what's recruiting

The Fort Wayne area currently has 116 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Fort Wayne, the most active research areas are:

  • Cancer & Oncology17 studies
  • Heart & Vascular2 studies
  • Brain & Mental Health1 studies

Every listing shows the study phase, the recruiting site and its distance from Fort Wayne, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Fort Wayne

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Fort Wayne participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Fort Wayne pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Fort Wayne?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
What is the difference between a research center and a hospital study in Fort Wayne?
Dedicated research centers (listed on this page with their Google ratings) run studies as their core business — often healthy-volunteer and vaccine studies with structured compensation. Hospital and university studies tend to focus on patients with specific conditions. Both types are registered and IRB-supervised.
How often do new paid studies open in Fort Wayne?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Fort Wayne.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Fort Wayne typically complete one or two studies per year.

Paid clinical trials near Fort Wayne

Other metros within reach

By condition

Eligibility and exclusions, condition by condition

More of IN

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts